Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease atrial fibrillation
Phenotype C0022658|renal disease
Sentences 11
PubMedID- 24599151 Furthermore, there is emerging evidence that rdn may have a role in the treatment of heart failure, obstructive sleep apnea, insulin resistance, atrial fibrillation and hypertension associated with end-stage renal disease.
PubMedID- 26322603 Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.
PubMedID- 23114904 Background: the reported incidence, prevalence and outcomes of atrial fibrillation (af) in patients with end-stage renal disease (esrd) are variable.
PubMedID- 21353064 Background: the prevalence of atrial fibrillation is increased in patients with end-stage renal disease.
PubMedID- 25032883 End-stage renal disease with atrial fibrillation: uncharted territory in the modern world of anticoagulants.
PubMedID- 25587708 Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.
PubMedID- 22016590 Statins have shown additional pleiotropic effects beyond their lipid-lowering effect; they improve endothelial function, reduce inf lammation and coronary artery thrombus, and decrease left-ventricular mass, blood pressure, left-ventricular fibrosis, cardiac-valve sclerosis, atrial fibrillation, and mortality in patients with diabetes and renal disease [6-11].
PubMedID- 24026242 Balancing thromboembolic risk against vitamin k antagonist-related bleeding and accelerated calcification: is fondaparinux the holy grail for end-stage renal disease patients with atrial fibrillation.
PubMedID- 24952148 Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
PubMedID- 21851395 Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation.
PubMedID- 19923144 Outcome of atrial fibrillation among patients with end-stage renal disease.

Page: 1